Mitral valve replacement with the pulmonary autograft: Ross II procedure with Kabanni modification

Research output: Contribution to journalArticle

3 Scopus citations


We report our experience with pulmonary autograft replacement of the mitral valve in eight patients. Hospital mortality of 0% was reported, and there has been one autograft failure requiring replacement (mean follow-up 12 ± 6 months). We also review the world's experience with this technique. Mitral valve replacement with a pulmonary autograft (Ross II) is safe, reproducible, and possible warranted for selected patients.

Original languageEnglish (US)
Pages (from-to)107-114
Number of pages8
JournalPediatric Cardiac Surgery Annual
Issue number1
StatePublished - Jan 1 2004



  • Mitral valve replacement
  • Pulmonary autograft
  • Ross procedure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this